Catalent

More from Catalent
The partnership will include the provision and accelerated delivery of advanced visual inspection systems to help with potential solutions to the pandemic.
Partnership to Expedite Installation of Automated Inspection Equipment
Stevanato Group high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in the US and Italy.
Oct 28th, 2020
Covid Home
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
The agreement accelerates the rapid scale-up of capacity over the coming months to support the dedicated production of AZD1222.
Jun 24th, 2020
Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy
Bristol-Myers Squibb will maintain strategic presence in Italy through ongoing development and commercialization of new medicines. Catalent will continue to manufacture products for Bristol-Myers Squibb while offering other customers access to state-of-the-art sterile biologics fill/finish and oral solids manufacturing and packaging platforms
Jun 19th, 2019
Catalent Expands Clinical Packaging in Shanghai
The expansion includes a new automated, high-speed bottling line suitable for capsule and tablet products.
Dec 6th, 2018
Catalent’s Bloomington facility serializes and aggregates vials and syringes.
Fitting track and trace into a patient-first culture
Catalent’s Bloomington, IN facility meets U.S. and European regulatory deadlines via a turnkey approach on a vial and syringe packaging suite.
Nov 13th, 2018
Fitting Track and Trace into a Patient-First Culture
Catalent’s Bloomington, IN facility meets U.S. and European regulatory deadlines via a turnkey approach on a vial and syringe packaging suite.
Nov 12th, 2018
Catalent’s Bloomington facility serializes and aggregates vials and syringes.
Fitting Track and Trace into a Patient-First Culture
Catalent’s Bloomington, IN facility meets U.S. and European regulatory deadlines via a turnkey approach on a vial and syringe packaging suite.
Nov 12th, 2018
Catalent Completes Clinical Storage Expansion in Kansas City
Second phase of $5.5 million expansion program to increase the controlled-substance and controlled-temperature storage capabilities for its clinical supply business.
May 21st, 2018
Catalent Completes $5.5 Million Philadelphia Expansion
Includes 40% increase in pallet space for both refrigerated and ambient clinical storage, cold chain and clinical label control areas.
Apr 16th, 2018